Semaglutide offers a sustained reduction in HbA1c and body weight in patients with T2D: Real-world data from the MHS database

The impact of novel antidiabetic agents on stroke, MI, and mortality in T2D patients: a nationwide cohort study

Exploring the prospects of patient-oriented management of diabetes: The 2nd consensus report of the ADA/EASD Precision Medicine in Diabetes Initiative

Empagliflozin as an efficacious novel oral option for youth-onset type 2 diabetes patients without insulin therapy: Post-hoc analysis of the DINAMO trial

26-week treatment of dapagliflozin exhibits remarkable efficacy and tolerability among children and adolescents with T2D: Analysis of the phase 3 T2NOW study

Combined antiviral treatment of pleconaril and ribavirin decelerates the development of newly diagnosed type 1 diabetes in adolescent populations: Results from the DiViD Intervention study

Tirzepatide demonstrates efficacy in maintaining body weight reduction in obese patients in the SURMOUNT-4 trial

isCGM exhibited remarkable efficacy as an adjunct to lifestyle modification in patients with impaired glucose tolerance: Interim analysis of the Flash LMP study